Peptides and monoclonal antibodies which bind to platelet glycoproteins IIb and/or IIIa inhibit clot retraction
- 1 January 1988
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 49 (1), 43-53
- https://doi.org/10.1016/0049-3848(88)90358-1
Abstract
No abstract availableFunding Information
- National Institutes of Health (BRSG SO7 RR07229, HL 35586)
This publication has 49 references indexed in Scilit:
- The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood plateletsBlood, 1987
- Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the .gamma. chainBiochemistry, 1984
- Ultrastructure of clots during isometric contraction.The Journal of cell biology, 1982
- The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresisBlood, 1981
- Exposure of platelet fibrinogen receptors by ADP and epinephrine.JCI Insight, 1979
- Fibrinogen and ADP-induced platelet aggregationBlood, 1978
- Fibrin-Blood Platelet Interaction in a Contracting ClotBritish Journal of Haematology, 1975
- Thrombin substrates and the proteolytic site of thrombin action on human-platelet plasma membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974
- Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of plateletsJCI Insight, 1970
- The Fibrinolytic Activity of Normal BloodBritish Journal of Haematology, 1955